000 | 01615 a2200421 4500 | ||
---|---|---|---|
005 | 20250514230610.0 | ||
264 | 0 | _c20051011 | |
008 | 200510s 0 0 eng d | ||
022 | _a1096-6374 | ||
024 | 7 |
_a10.1016/j.ghir.2005.03.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTanriverdi, F | |
245 | 0 | 0 |
_aEffects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome. _h[electronic resource] |
260 |
_bGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _cJun 2005 |
||
300 |
_a231-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 | _aBlood Pressure |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHormone Replacement Therapy |
650 | 0 | 4 |
_aHuman Growth Hormone _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypopituitarism _xdrug therapy |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aUnluhizarci, K | |
700 | 1 | _aKula, M | |
700 | 1 | _aGuven, M | |
700 | 1 | _aBayram, F | |
700 | 1 | _aKelestimur, F | |
773 | 0 |
_tGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society _gvol. 15 _gno. 3 _gp. 231-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ghir.2005.03.005 _zAvailable from publisher's website |
999 |
_c15583212 _d15583212 |